Andrew Barnstein is a Cardiologist in Pikesville,, Maryland. Dr. Barnstein is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), and Atrial Tachycardia.

Charles Cummings is a Cardiologist in Pikesville,, Maryland. Dr. Cummings is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, Pacemaker Implantation, and Heart Bypass Surgery.

Jonathan Dubin is a Cardiologist in Pikesville,, Maryland. Dr. Dubin is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atrial Fibrillation, Inappropriate Sinus Tachycardia (IST), Fainting, and Familial Neurocardiogenic Syncope.

Ambereen Quraishi is a Cardiologist in Pikesville,, Maryland. Dr. Quraishi is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Atrial Fibrillation, Wolff-Parkinson-White Syndrome, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Zalman Kahn is a Cardiologist in Pikesville,, Maryland. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Arrhythmias, Atrial Fibrillation, Familial Dilated Cardiomyopathy, and Glucocorticoid-Remediable Aldosteronism.

Jonathan Rogers is a Cardiologist in Pikesville,, Maryland. Dr. Rogers is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), His Bundle Tachycardia, and Paroxysmal Supraventricular Tachycardia (PSVT).

Julia Wen is a Cardiologist in Baltimore,, Maryland. Dr. Wen is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Heart Murmurs, and High Cholesterol.

Sunal Makadia is a Cardiologist in Baltimore,, Maryland. Dr. Makadia is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Familial Dilated Cardiomyopathy, and Angina.

Mohammed Abuzahra is a Cardiologist in Baltimore, Maryland. Dr. Abuzahra is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Coronary Heart Disease, Heart Attack, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Pacemaker Implantation.

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

James Gammie is the surgical lead and co-director for the Johns Hopkins Heart and Vascular Institute and cardiac surgeon-in-chief for the Johns Hopkins Health System. With over 23 years of experience in cardiothoracic surgery, Dr. Gammie joined Johns Hopkins after serving as chief of the division of cardiac surgery at the University of Maryland Medical Center from 2012 to 2021. Dr. Gammie graduated from Brown University with a degree in biochemistry, and received his medical degree from the University of Massachusetts Medical School. Dr. Gammie trained in both general and cardiothoracic surgery at the University of Pittsburgh School of Medicine. His clinical and research efforts are focused on decreasing the mortality and morbidity of valve disease and improving the surgical treatment of mitral valve and other structural heart diseases. He performs over 225 mitral valve operations and interventions per year, and leads a cardiac surgery team that performs more than 1,200 cardiac operations annually. He is recognized by the Mitral Foundation and the American Heart Association as one of less than 25 reference surgeons in the U.S. for his experience in mitral valve repair and excellent patient outcomes. Dr. Gammie has a strong interest in all aspects of heart valve disease, and has published more than 200 peer-reviewed contributions in leading specialty journals including The New England Journal of Medicine, the Journal of Thoracic and Cardiovascular Surgery and Circulation. He has served as a deputy editor for The Annals of Thoracic Surgery and as chair of the Access and Publications Committee of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. He serves on the steering committee of the NHLBI-sponsored Cardiothoracic Surgery Trials Network, and led the protocol development committee of a worldwide randomized tricuspid valve surgery trial. He is a member of the Halsted Society and the 21st Century Cardiothoracic Surgical Society. In 2011, Dr. Gammie was awarded the Johns Hopkins/University of Maryland Alliance for Science and Technology Development BioMaryland LIFE Prize, and he was named Entrepreneur of the Year at the University of Maryland Baltimore in 2014. He is the inventor of a novel transseptal catheter designed to simplify transcatheter cardiac procedures, and founded a commercial company to commercialize the device. With 20 issued or submitted patents, he continues to innovate in the mitral valve space, and recently published the world’s first clinical experience with a novel surgical repair for secondary mitral valve regurgitation, which was developed in his laboratory: mitral valve translocation. From 2016–2021, Dr. Gammie was consistently named a Top Doctor by Baltimore magazine, and in 2018 he received the Golden Apple Teacher of the Year award. Dr. Gammie is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery.

Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Dr. Reed David Riley is an assistant professor of medicine at the Johns Hopkins University School of Medicine and chief of cardiology at the Greater Baltimore Medical Center. Dr. Riley received his undergraduate degree from Duke University. He earned a medical degree from The Johns Hopkins University School of Medicine and completed a residency at Johns Hopkins Hospital. Prior to joining Johns Hopkins in 2007, Dr. Riley was a cardiology fellow at Duke University and staff cardiologist at Sinai Hospital of Baltimore. He is currently also a teaching attending on the Osler Medical Service’s Barker Firm at the Johns Hopkins Hospital. Dr. Riley is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Angina.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Frank Morris is a Cardiologist in Lutherville Timonium, Maryland. Dr. Morris is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Atrial Fibrillation, Atherosclerosis, Coronary Heart Disease, and High Cholesterol.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Chetan Pasrija, M.D. is a cardiothoracic surgeon in Baltimore, Maryland. He is an assistant professor of surgery at the Johns Hopkins University School of Medicine. Dr. Pasrija specializes in heart and lung transplantation, aortic surgery, and the surgical treatment of ischemic heart disease. He also has a particular interest in chronic thromboembolic pulmonary hypertension. He has published extensively on the topics of heart and lung transplant, massive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and minimally invasive left ventricular assist device implantation. As a trainee, Dr. Pasrija was heavily involved with the surgical implantation and postoperative management of the first cardiac xenotransplant performed in the world at the University of Maryland. During his time as faculty at Vanderbilt University, he was a part of one of the largest heart and lung transplant programs in the United States. This included significant involvement with cutting-edge technologies to expand the donor pool, including normothermic regional perfusion and the Transmedics Organ Care System. Dr. Pasrija was co-surgeon in a combined heart-lung transplant with a groundbreaking 9.5 hour period of time without any blood flow using a novel 10⁰C cooler. He has also performed heart transplants with travel as far as Puerto Rico. Outside of transplantation, Dr. Pasrija is a high-volume cardiac surgeon, with an interest in complex open and endovascular aortic surgery. He performed the first ascending stent in the state of Tennessee, as well as the first total arch replacement without cooling the patient’s body in Tennessee using the Thoraflex device. He earned his Bachelor of Science Degree in Bioengineering at the University of Maryland and his Medical Degree at the University of Maryland School of Medicine. He completed an Integrated Cardiothoracic Surgery residency at the University of Maryland. During his training, he spent time at Vanderbilt University to learn advanced heart failure techniques as well as time at the University of Toronto to learn advanced lung transplant and pulmonary thromboendartectomy techniques. Additionally, he has a Masters in Clinical Research from the University of Maryland. Outside of his clinical interests, Dr. Pasrija is an accomplished investigator. During his post-doctoral research fellowship, he received a competitive American Heart Association post-doctoral fellowship award in addition to institutional awards for excellence in research. His research efforts focus on improving donor preservation with novel perfusion and temperature techniques, improving donor evaluation methods, and establishing novel immunologic therapies for transplant tolerance. Dr. Pasrija is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Dissection, Embolectomy, and Heart Transplant.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Strahan is currently employed as an Active Part time cardiologist. She currently is employed solely for the purpose of interpreting echocardiograms and no longer sees patients. Dr. Strahan is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Adenosine Deaminase 2 Deficiency, Brugada Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS), and Short QT Syndrome.

Elizabeth Loeb is a primary care provider, practicing in Internal Medicine in Pikesville, Maryland. Dr. Loeb is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Prolapse. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D). Dr. Loeb is currently accepting new patients.